NasdaqCM - Delayed Quote USD

Celularity Inc. (CELU)

Compare
2.5100 -0.2400 (-8.73%)
At close: October 18 at 4:00 PM EDT
2.8000 +0.29 (+11.55%)
After hours: October 18 at 5:41 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for CELU

Recent News: CELU

View More

Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound? Product from Sequence LifeScience, Inc.

Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment Conference

Celularity Appoints Richard J. Berman to its Board of Directors

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

Celularity Reports Full Year 2023 Combined Net Sales of $22.8 Million, a 26.7% Increase Over Full Year 2022, and Announces First Half 2024 Expected Combined Net Sales of $26.9 Million Representing 290% Growth Over First Half 2023

Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting

Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy

Celularity Inc. to Host Investor and Analyst Research & Development Day

Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024

Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products
View More

Related Tickers